IL-6 and cfDNA monitoring throughout COVID-19 hospitalization are accurate markers of its outcomes

BACKGROUND: Severe COVID-19 entails a dysregulated immune response, most likely inflammation related to a lack of virus control. A better understanding of immune toxicity, immunosuppression balance, and COVID-19 assessments could help determine whether different clinical presentations are driven by...

Descripción completa

Detalles Bibliográficos
Autores principales: Bello, Salvador, Lasierra, Ana Belén, López-Vergara, Lucía, de Diego, Cristina, Torralba, Laura, de Gopegui, Pablo Ruiz, Lahoz, Raquel, Abadía, Claudia, Godino, Javier, Cebollada, Alberto, Jimeno, Beatriz, Bello, Carlota, Tejada, Antonio, Torres, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161166/
https://www.ncbi.nlm.nih.gov/pubmed/37147677
http://dx.doi.org/10.1186/s12931-023-02426-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161166/
https://www.ncbi.nlm.nih.gov/pubmed/37147677
http://dx.doi.org/10.1186/s12931-023-02426-1

Ejemplares similares